Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria
Recruiting
Observational Study
Interstitial Lung Disease
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 400 (estimated)
- Sponsor
- Ludwig Boltzmann Institute for Lung Health · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this registry is to systematically record epidemiological and clinical data throughout the whole interstitial lung disease course - starting with the diagnosis, therapy, follow up of lung function, symptom control, adverse events, medication, survival and death. There are no additional interventions regarding this registry.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* diagnosis of interstitial lung disease
* written informed consent
Exclusion Criteria:
* to not comprehend and rightfully judge participation
Contacts
No contact information available.